Showing results (391-400 of 486) with videos related to

Sort By:
Pageof 49
Oncoimmunology|March 24, 2021
TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patientsJana Rakova, Iva Truxova, Peter Holicek, et al.
Blood|November 3, 2016
Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patientsJitka Fucikova, Iva Truxova, Michal Hensler, et al.
Autophagy|June 1, 2012
Immunohistochemical detection of cytoplasmic LC3 puncta in human cancer specimensSylvain Ladoire, Kariman Chaba, Isabelle Martins, et al.
Cell Cycle (Georgetown, Tex.)|January 25, 2013
Role of the c subunit of the FO ATP synthase in mitochondrial permeability transitionMassimo Bonora, Angela Bononi, Elena De Marchi, et al.
Oncoimmunology|July 3, 2015
Trial Watch: Immunomodulatory monoclonal antibodies for oncological indicationsAitziber Buqué, Norma Bloy, Fernando Aranda, et al.
Molecular Cell|November 29, 2007
Nonapoptotic role for Apaf-1 in the DNA damage checkpointYael Zermati, Shahul Mouhamad, Lilli Stergiou, et al.
Oncoimmunology|December 8, 2018
PD-L2 amplification and durable disease stabilization in patient with urothelial carcinoma receiving pembrolizumabSaby George, Antonios Papanicolau-Sengos, Felicia L Lenzo, et al.
Oncoimmunology|June 7, 2018
Trial Watch: Immunostimulation with recombinant cytokines for cancer therapyElena García-Martínez, Melody Smith, Aitziber Buqué, et al.
Cell Cycle (Georgetown, Tex.)|January 25, 2013
Prognostic value of LIPC in non-small cell lung carcinomaLorenzo Galluzzi, Aicha Goubar, Ken André Olaussen, et al.
Iscience|July 2, 2025
Spatial transcriptomic analysis of immune checkpoint blockade response in triple negative breast cancers with tertiary lymphoid structuresRichard H Mebane, Teia Noel, Nathan Ing, et al.
Pageof 49